Trials / Conditions / Severe Aplastic Anemia (SAA)

Severe Aplastic Anemia (SAA)

10 registered clinical trials studyying Severe Aplastic Anemia (SAA) — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA NCT07523009	Peking Union Medical College Hospital	Phase 2
Withdrawn	Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppres NCT05323617	Amgen	Phase 2
Enrolling By Invitation	Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of NCT07299123	Chinese PLA General Hospital	Phase 1 / Phase 2
Terminated	REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive NCT04409080	Regeneron Pharmaceuticals	Phase 1
Completed	Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia NCT04328727	Novartis Pharmaceuticals	Phase 2
Recruiting	Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood St NCT03520647	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia NCT01900119	National Institutes of Health Clinical Center (CC)	—
Completed	Extended Dosing With Eltrombopag for Severe Aplastic Anemia NCT01891994	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodyspl NCT00604201	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Comparing Therapies for the Treatment of Severe Aplastic Anemia NCT00001626	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2